New York and Brussels, July 30, 2009 – Heartbeat, the leading global provider of Key Opinion Leader (KOL) management solutions, has reported signing 12 new Life Sciences clients in the first two quarters of 2009. The clients are distributed globally and represent a range of medical affairs departments, brand teams, and market access clients.
“We are thrilled with our continued growth and market share in Life Sciences,” said Jonah Meyers, President of Heartbeat. “Our software division, Heartbeat Software, and our consulting division, Heartbeat Experts, are both thriving in a difficult economy, which is a testament to the maturity and quality of our products and services.”
According to Larry Cohen, Global EVP at Heartbeat, “The KOL landscape is constantly evolving and our clients are beginning to look beyond managing only physician KOL’s. For example, today we are helping our clients manage and identify influencers that may have an impact on a product’s Market Access strategy.”
“New clients translate to improved products,” said Chris Michaud, Global VP of Product Management.” “Rather than traditional CRM functionality, our clients have demanded niche KOL Management functionality that addresses their specific business problems, and we have delivered time and time again.”
Heartbeat, and its two divisions, Heartbeat Software and Heartbeat Experts, is the leading global provider of Key Opinion Leader Management solutions. With offices in five countries and expertise in twelve major therapeutic areas, Heartbeat works with fifteen of the top thirty pharmaceutical and biotech companies on KOL identification, KOL Segmentation, KOL Profiling, KOL Influence Mapping, KOL Planning and Market Access.
For more information or to schedule a consultation call the U.S. Headquarters at (212) 941-9041 or the European Headquarters at (32) 2 400 00 22 or visit www.heartbeatsoftware.com or www.heartbeatexperts.com.
In today’s healthcare environment, life sciences companies face pricing, reimbursement, policy and regulatory challenges. In meeting these challenges…
A leading pharmaceutical enterprise was conducting several clinical trials in various stages on a compound, and realized…
© 2011 Heartbeat Experts. All rights reserved